We use advanced photocatalysis and electrocatalysis to make chemical processes more efficient, and precise beyond what traditional methods can achieve.
These advanced catalytic approaches open new avenues for accessing complex molecular architectures, facilitating late-stage functionalization, and enabling reactions under milder conditions. Photochemical and electrochemical methodologies also offer unique opportunities to streamline routes, reduce environmental impact, and improve overall reaction efficiency.
By integrating these technologies into our medicinal chemistry workflows, we deliver scalable solutions to accelerate drug discovery, enhance molecular diversity, and support the development of more effective therapeutic molecules.
Photocatalysis:
Objectives: To apply the latest advancements in photocatalyzed transformations to accelerate medicinal chemistry programs and expand the accessible chemical space. This is achieved by unlocking novel reactivity pathways through light-driven transformations that enable innovative and efficient synthetic strategies.
Activities: Photoredox catalysis has rapidly evolved from a niche innovation to a game-changing tool in early-stage research. Its appeal lies in its simplicity, versatility, and unique ability to unlock transformations, making it an essential tool for modern medicinal chemistry. At Novalix, we continue to invest in our photoredox platform to stay at the forefront, enabling a wide range of photocatalyzed transformations, from mg to gram scale.
Our infrastructure includes:
- A range of commercial photoredox reactors covering multiple wavelengths.
- Internally designed photoreactors.
- HTE (High-Throughput Experimentation) photoredox capabilities, facilitating rapid reaction optimization and scalability.
To learn how we leverage this technology, read the following article: https://novalix.com/2023/photoinduced-minisci-reaction-with-diazines/